Skip to main content

What is a Digital therapeutics & Its Future

 What is a Digital therapeutics:

Digital therapeutics (DTx) are a digital health category defined by the Digital Therapeutics Alliance as products that “deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease.

Future of Digital therapeutics:

Advances in and the increasingly dominant role of mobile technology and artificial intelligence (AI) in our everyday lives have broadened the role of DTx in healthcare. Although, historically, interest in developing DTx was mainly confined to academia and technology companies, the potential to use DTx in conjunction with medicines to improve health outcomes has sparked the interest of big pharma, who have started to venture into the DTx space through investments and strategic partnerships with tech companies.

A significant change in the usage of digital technology has created cognizance among users and has allowed increasing adoption of these services. Moreover, there has been increased burden of the chronic diseases that requires effective treatment and management. There are a lot of services provided by digital therapeutics that aid in embracing healthy habits and allow efficient tracking and management of conditions. Digital therapeutics is thus estimated to grow at a fast rate owing to increasing adoption among patients and other end users.

The global DigitalTherapeutics market size was estimated at USD 1.7 billion in 2016. Digital therapeutics is a subset of digital health and is used to track health conditions and self-management of a medical condition. There has been a significant rise in internet usage among people which has been one of the significant drivers for the digital therapeutic market. Moreover, the treatment associated with the digital therapeutics is popular which is further adding to the growth of the digital therapeutic market. Chronic diseases are major problems and act as threats to the economy leading to high healthcare expenditure. For instance, according to the CDC, about 50 % of the adult population were suffering from the chronic diseases in 2012. As chronic diseases like diabetes, obesity and other respiratory problems are well managed with the help of the digital therapeutics they are being used on an increasing level.

The market growth is affected by the lack of the effective monetization techniques which are faced by the application developers. There has been a shortage of the financial earnings which are partially fulfilled by the advertisements, paid content, and other prominent revenue generation strategies.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/digital-therapeutics-market/request-sample

 

Appliactions of Digital therapeutics:

Hospitals accounted for the largest market share owing to increased usage of digital therapeutics services for patients admitted in these settings. The utilization of these services allows affordable and vital healthcare to patients.

Based on the application, the market is classified into diabetes, obesity, cardiovascular diseases, central nervous system disease, respiratory diseases, smoking cessation, and others. Diabetes accounts for the largest market share of the application segment followed by other applications. Diabetes causes heavy burden on patients as well economies on the health front as well as the economic front. For instance, 8.3 % of the U.S. population suffer from diabetes while 35% of them exhibit prediabetes symptoms. Also diabetes is expected to show the fastest growth in the application segment due to the high prevalence and incidence of the disease. Digital management is helpful in the management of the symptoms of diabetes such as polyuria, polydipsia, and polyphagia. A large number of medical practitioners are using mHealth and have estimated that diabetes would reach its highest market limit in the next 5 years.

Based on end use, the digital therapeutics market is divided into the patients, employers, providers, payers, and others. Patients are the major consumers of the therapeutic healthcare programs and applications offered by digital therapeutics. The usage of these services has been attributed due to increasing cognizance and added benefits offered by digital therapeutics.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/digital-therapeutics-market

Application:

        • Diabetes
        • Obesity
        • CVD
        • CNS Disease
        • Respiratory Diseases
        • Smoking Cessation
        • Others

The digital therapeutics market by region is characterized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a market dominator in digital therapeutic market. Growing number of reforms to limit the surge in healthcare expenditure in the country coupled with drive to focus on a patient-centric healthcare approach is anticipated to be accountable for the same. Furthermore, North America is a major center of a great amount of digital therapy suppliers. The U.S. has been conveyed to spend about USD 3 trillion a year on healthcare. In order to limit this expenditure, there is a vigorous swing in the U.S. healthcare sector that emphasis focused towards palliative care, to endorse overall patient wellness as an alternative of medical treatment.

Asia Pacific is anticipated to record fastest growth rate, due to two main attributes, namely, a highly solid population base that adapts into an enormous target base and rapid development that involves fast changing technological scenario. Moreover, constant improvements in countries to check the deficiency of proper infrastructure and preserve sustainable growth through economic intervention is expected to help the market growth

Competitive Insights

Some of the key companies in the market comprises of Livongo Health; Twine health, Inc.; Omada Health, Inc.; 2Morrow, Inc.; Propeller Health; WellDoc, Inc.; Canary Health, Inc.; Proteus Digital Health, Inc.; and Mango Health, Inc. Digital therapeutics is in its preliminary stages of development and is expected to increase its presence in the digital market with increasing adoption of apps and services offered by developers. Dominant players in the market are focused on development of user friendly and simple interfaces that allows customers to use these services on a larger level at ease.

However, growth probability is considered to be great in the market, which is contributed by growing adoption of therapeutic applications by leading healthcare providers to provide better treatment options to patients.

Read more insights on @

https://latestmarkettrends.news.blog

 

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Comments

Popular posts from this blog

Aesthetic Medicine Market Worth About USD 11.9 billion By 2024

  Global Aesthetic Medicine Market is anticipated to reach USD 11.9 billion by 2022. Aesthetic medicine is a wide-ranging term for specialties that emphasize on improving cosmetic appearance through the treatment of situations including skin laxity, scars, wrinkles, excess fat, unwanted hair, skin discoloration. The factors that propel the growth of the Aesthetic Medicine Market include rising awareness regarding aesthetic procedures. In addition, growing demand for the use of minimally invasive equipment, rapid technological advancement, and increase in disposable incomes. On the other hand, there are factors that may hamper the growth of the market including poor compensation structures and probable health risks related with the procedures. The market is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe. Market may be explored by product type, application, and geography. Aesthetic M...

Paint Additives Market To Show Tremendous Rise In Upcoming Year

Paint additives market is expected to reach USD 10.9 billion by 2025. Growing use of paints and coatings in the construction and the automotive sectors due to highly preferred solvent properties are major growth factors. Other factors such as increase in the expenditure on construction activities and rise in the adoption of paints and coatings in automotive sector, are fueling growth of the paint additives market, mainly in developing economies across the globe. The increasing use of paints and coating is expected to influence demand for paint additives in the forecast period. Paint additives market is expected to witness 6% CAGR in the forecast period. The stringent laws and regulation against harmful effects of paints and coating on environment are compelling market players to adopt environment-friendly paints and coatings additives that complies with the regional and international regulations. This has led market players to significantly invest in research and development for pain...

Thyroid Gland Disorder Treatment Market Worth About 2.6 billion By 2024

Thyroid Gland Disorder Treatment Market is estimated to stretch US$ 2.6 billion by the year 2025. Growth in occurrence of thyroid diseases, everywhere in the world, is likely to motivate the demand for anti-thyroid medications in the approaching years. Hypothyroidism is one of the most important reasons for hospitalization in the U.S. Increasing consciousness about sickness administration between healthcare specialists and patients is additional reason boosting the progress of the market. The thyroid gland disorder treatment industry will develop by a CAGR of 3.2% for the duration of the prediction. The thyroid gland disorder treatment market on the source of Type of Delivery Network could span Online Delivery, Wholesaler/Distributors, Retail Chain, and Others. The wholesalers and distributors form a somewhat complete subdivision. Yet, greater infiltration of these delivery networks for prescription medicines has permitted it to increase the biggest income stake since 2016. Wholesale...